Information Library

Results for: Case Studies - Clinical Monitoring

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Energizing Enrollment

    October 4, 2011
    The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned.

  • Asia-Pacific Expertise

    May 11, 2011
    Quintiles' experience and flexibility to understand cultural and communication differences across Asia Pacific provided an integrated solution which exceeded recruitment targets.

  • Advancing Vaccine Development in Australia and New Zealand

    April 11, 2011
    Quintiles rose to the challenge of a very aggressive vaccine recruitment timeline during the holiday period - and recruited 3,000+ subjects from 18-90 years of age within just 17 days - 25 days ahead of schedule.

  • Constant Vigilance

    March 16, 2011
    Centralized planning played a key role in improving productivity during site visits and close monitoring ensured the high standards Quintiles put in place were met.

  • Recruiting Trust

    March 16, 2011
    Quintiles enrolls 2 cancer trials, 2 times faster than projected

  • Competitive Edge - Ulcerative Colitis

    February 2, 2011
    Although faced with the challenge of recruiting for this small patient population, enrollment was completed two months ahead of schedule.

  • Timely Results - Flu Vaccine

    February 2, 2011
    Streamlined processes for study startup, coupled with experience in vaccine trials and solid relationships with study sites and investigators, helped this Quintiles team meet the challenge of starting an influenza vaccine trial late in the influenza season.

  • Bypassing Barriers - Refractory Partial Epilepsy

    February 2, 2011
    Despite a difficult and limited patient population, Quintiles randomized 388 patients (13 over target) 10 weeks ahead of schedule.

  • Diabetes - Therapeutic Focus

    February 1, 2011
    A dose-ranging clinical study to evaluate the safety, efficacy and tolerability of five doses of Drug X compared with placebo in Type II diabetes patients with no prior exposure to anti-diabetic medication.

  • Parkinson's Disease - Ambitious Recruitment

    February 1, 2011
    Quintiles provided project management, clinical monitoring, and more for a study of a drug for patients with early stage idiopathic Parkinson’s disease.

Page 1 of 3 (26 results)

Subscribe to Email Based on Your Interests

Set preferences